Objective: To evaluate the sensitivity of acid-fast sputum smears in the diagnosis of pulmonary Mycobacterium tuberculosis (MTB). Design 
Of the non-HIV-infected patients, 43 of 76 (57 percent) had positive acid-fast smears, compared with 60 of 100 (60 percent) of the HIV-infected patients. Among the latter group, 26 of 100 (26 percent) had disseminated disease, including isolation of MTB from blood (n= 10), extrathoracic lymph nodes (n=5), urine (n=5), cerebrospinal fluid (n=4), bone marrow (n=l), and stool (n1=); 25 of 26 (96 percent) of HIV-infected patients with disseminated disease had positive acid-fast sputum smears. None of the non-HIV-infected patients had disseminated disease.
Drug-resistant organisms were found in 13 of 69 (18 percent) of the non-HIV-infected patients, including 7 with multidrug-resistant organisms. Among the HIV-infected patients, 38 of 89 (42 percent) had resistant organisms, including 25 with multidrug resistance. Overall, 25 of 38 (66 percent) of HIVinfected patients with resistant organisms had positive acid-fast smears. Table 1 compares chest radiographic findings of patients with and without HIV infections, along with the frequency of a positive acid-fast smear. Significantly more non-HIV-infected patients had cavitary infiltrates (p<0.01) than HIV-infected patients; more HIV-infected patients had normal chest radiographs, however (p<0.05). No significant differences between the HIV-infected and non-HIV-infected patients were found in the frequency of positive acidfast sputum smears, stratified by chest radiographic findings.
Among the HIV-infected patients, no significant differences were found in the frequency of positive acid-fast sputum smears between groups stratified by CD4 cell counts (Table 2) . Our data confirm the finding that positive acid-fast sputum smears are found as frequently in patients with, as in those without, HIV infection and pulmonary MTB. Although cavitary disease was significantly less frequent among the HIV-infected patients, this form of disease, when present, resulted in the highest frequency of acid-fast smear positivity, similar to that observed among the patients without HIV infection (84 percent vs 85 percent). In addition, the frequency of acid-fast sputum smears in association with noncavitary infiltrates was similar for patients with and without HIV infection (58 percent vs 50 percent).
Patients with HIV infection did have a significantly greater number of normal chest radiographs, in the presence of pulmonary MTB, than those without HIV. However, the absence of parenchymal infiltrates on chest radiographs did not substantially reduce the likelihood of a positive sputum smear in the patients with HIV infection. Seven of the 18 patients with HIV infection and normal chest radiographs still demonstrated sputum smears positive for acid-fast bacilli. The finding that lack of parenchymal tissue destruction, and cavitation in particular, does not substantially reduce the yield of acid-fast CHEST / 106/3/ SEPTEMBER, 1994 685 smears has been observed previously." 9 Long et a19 suggested that, in cases of pulmonary MTB associated with profound immunosuppression from HIV, caseation necrosis may be less relevant to the yield of acid-fast smears than the unchecked proliferation of bacilli as seen with other opportunistic infections. Our data support this explanation; the frequency of positive acid-fast smears was 56 and 58 percent in the subgroups of patients with the highest and lowest CD4 cell counts, respectively.
Drug sensitivity also did not influence the likelihood of a positive acid-fast smear in HIV-infected patients with MTB. Overall, drug resistance was found in 42 percent of HIV-infected patients and multidrug resistance was found in 28 percent. The 65 percent frequency of a positive acid-fast smear in the 25 HIV-infected patients with resistant MTB was not significantly different from the frequency of a positive smear in the HIV-infected group overall. This finding is consistent with the study of Fischl et all' that reported 58 percent of patients with multidrugresistant MTB had positive acid-fast smears.
The presence of disseminated MTB, however, did increase the likelihood of a positive acid-fast smear in patients with HIV infection. Of the 26 patients with disseminated MTB, 25 (96 percent) had positive acid-fast smears. This finding may be due to the general increase in organism burden in disseminated disease and, specifically, to the lung's place as the original site of infection.
In conclusion, positive acid-fast sputum smears in culture-proven MTB occurred with similar frequency in patients with and without HIV infection. Chest radiographs with cavitary or noncavitary infiltrates were also associated with similar rates of acid-fast smear positivity in both patient groups. In patients with HIV infection, the frequency of positive acidfast smears was independent of CD4 cell counts and drug resistance. Lastly, in patients with HIV infection and disseminated MTB, acid-fast sputum smears were positive in nearly all cases.
